202798-06-9

Usage

Uses

Used in Pharmaceutical Industry:
4-PENT-1-ENYL-BENZOIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. Its unique structure allows it to be a building block in the creation of molecules with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-PENT-1-ENYL-BENZOIC ACID is utilized as a precursor in the production of agrochemicals, potentially enhancing the effectiveness of pesticides or other agricultural chemicals by incorporating its structural elements into their design.
Used in Materials Science:
4-PENT-1-ENYL-BENZOIC ACID is used as a component in the development of new materials, leveraging its chemical properties to improve or create materials with specific characteristics required in various industrial applications.
Used in Flavor Industry:
Due to its potential to exhibit biological activity and unique aromatic properties, 4-PENT-1-ENYL-BENZOIC ACID is used in the flavor industry to develop new flavor compounds, enhancing the taste profiles of food and beverage products.
Each of these applications takes advantage of the compound's structural features, demonstrating the versatility and importance of 4-PENT-1-ENYL-BENZOIC ACID in multiple industries.

InChI:InChI=1/C12H14O2/c1-2-3-4-5-10-6-8-11(9-7-10)12(13)14/h4-9H,2-3H2,1H3,(H,13,14)/b5-4+

Upstream product

• 502-56-7 nonanone-5 
• 619-66-9 4-Carboxybenzaldehyde 

Relevant academic research and scientific papers

AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Abstract of the Disclosure Compounds are disclosed that have a formula represented by Formula I herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals in

AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Compounds are disclosed that have a formula represented by the following: Formula (I) The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, in

New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture

The present invention relates to carboxamide compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1, R2, R3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.

Synthesis of (E)-1-Aryl-1-alkenes via a Novel BF3·OEt2-Catalyzed Aldol-Grob Reaction Sequence

The reactions of aromatic aldehydes with ketones in the presence of various acids were examined. The reactions generate (E)-1-aryl-1-alkenes in the presence of boron trifluoride diethyl etherate in nonnucleophilic solvents.